Drug Markets/Abaloparatide

Abaloparatide

1 NDC across 1 manufacturer|0 Generic,1 Brand

Abaloparatide is used to treat postmenopausal osteoporosis, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Apr 28, 2017. In 2024, Medicare Part D spent $258 million on Abaloparatide across 89,000 claims for 17,000 beneficiaries.

Abaloparatide is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $1745.14 to $1745.14 per ML. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$1745.14 – $1745.14

per ML

7d Activity

1 flat

avg +0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing ABALOPARATIDE

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
TYMLOS 80 MCG DOSE PEN INJECTR
$1745.1403
per ML
—

Frequently Asked Questions

What is Abaloparatide used to treat?

Abaloparatide is used to treat postmenopausal osteoporosis, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Abaloparatide?

In 2024, Medicare Part D spent $258 million on Abaloparatide across 89,000 claims for 17,000 beneficiaries.

How many Abaloparatide products are on the market?

The Abaloparatide drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Abaloparatide?

NADAC reference prices for Abaloparatide range from $1745.1403 to $1745.1403 per ML.

Which manufacturers make Abaloparatide?

1 manufacturer lists Abaloparatide in NADAC. Ranked by number of NDCs, the largest are Radius Health, Inc. (1).